Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2026 ,inter alia, to consider and approve 1. Unaudited Financial ....

..':? Oxygenta e7 VIRUPAKSHA To, Date: 22.07.2026 The Manager BSE Limited P. J. Towers, Dalal Street Mumbai-400001 Dear Sir/ Madam, Unit: Oxygenta Pharmaceutical Ltd (Scrip: 524636) Sub: Intimation of the Board Meeting to be held on Saturday, 25 July, 2026 Pursuant to Regulation 29 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the Exchange that the Board Meeting of the Company will be held on Saturday, 25% July, 2026 at the corporate office of the Company to consider inter alia, the following: 1. Un-audited financial results for the quarter ended June 30, 2026. 2. Limited Review Report for the quarter ended June 30, 2026. 3. Any other business with the permission of the Chair. This is for the information and records of the Exchange, please. Thanking you. Yours sincerely, For Oxygenta Pharmaceutical Ltd Kumkum Bajaj Company Secretary & Compliance Officer OXYGENTA PHARMACEUTICAL LIMITED (Subsidiary of VIRUPAKSHA ORGANICS LIMITED) (An 1SO 9001:2015, ISO 14001:2018 and ISO 45001:2015 Certified Company) Regd off.& Factory: Sy.No. 252/1, Aroor (V), Sadasivapet (M), Sangareddy (Dist)-502 291, Telangana, INDIA. Tel: 08455-250080 Corp. Office: Level-1, Plot No. B1 & B2, IDA Gandhi Nagar, Kukatpally, Hyderabad — 500 037, Telangana, INDIA. E-Mailid: info@oxygentapharma.com. Website: www.oxygentapharmacom, Phone 040-23073417, CIN: L24110TG1990PLC012038